Skip to main content
SpringerLink
Log in

Risk of venous thromboembolism in patients with idiopathic inflammatory myositis: a systematic review and meta-analysis

  • Short Communication
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

We performed this meta-analysis to assess venous thromboembolism risk in patients with idiopathic inflammatory myositis (IIM). A comprehensive search was performed in MEDLINE, EMBASE and the Cochrane database. Three observational studies met our inclusion criteria and were included in the data analysis. The pooled risk ratio of venous thromboembolism in patients with IIM compared with non-IIM participants was 2.85 (95 % CI 2.12–3.84). Our result indicates a significant increased risk of venous thromboembolism among patients with IIM.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Naess IA, Christiansen SC, Romundstad P et al (2007) Incidence and mortality of venous thrombosis: a population-based study. J Thromb Haemost 5:692–699

    Article  PubMed  CAS  Google Scholar 

  2. Heit JA, Silverstein MD, Mohr DN et al (1999) Predictor of survival after deep venous thrombosis and pulmonary embolism: a population-based, cohort study. Arch Intern Med 159:445–453

    Article  PubMed  CAS  Google Scholar 

  3. Nagareddy P, Smyth SS (2013) Inflammation and thrombosis in cardiovascular disease. Curr Opin Hematol 20:457–463

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  4. Silvarino R, Danza A, Merola V, Berez A, Mendez E, Espinosa G, Cervera R (2012) Venous thromboembolic disease in systemic autoimmune diseases: an association to keep in mind. Autoimmun Rev 12:289–294

    Article  PubMed  CAS  Google Scholar 

  5. Ungprasert P, Srivali N, Spanuchart I et al (2014) Risk of venous thromboembolism in patients with rheumatoid arthritis: a systematic review and meta-analysis. Clin Rheumatol 33:297–304

    Article  PubMed  Google Scholar 

  6. Miehsler W, Reinisch W, Valic E et al (2005) Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism? Gut 53:542–548

    Article  Google Scholar 

  7. Selva-O’callaghan A, Fernandez-Luque A, Martinez-Gomez X et al (2011) Venous thromboembolism in patients with dermatomyositis and polymyositis. Clin Exp Rheumatol 29:846–849

    PubMed  Google Scholar 

  8. Gaitonde SD, Ballou SP (2008) Deep venous thrombosis in dermatomyositis. J Rheumatol 35(11):2288

    Article  PubMed  Google Scholar 

  9. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trial 7:177–188

    Article  CAS  Google Scholar 

  10. Higgins JP, Thompson SG, Deeks JJ et al (2003) Measuring inconsistency in meta-analyses. BMJ 327:557–560

    Article  PubMed  PubMed Central  Google Scholar 

  11. Ramagopalan SV, Wotton CJ, Handel AE et al (2011) Risk of venous thromboembolism in people admitted to hospital with selected immune-mediated diseases: record-linkage study. BMC Med 9:1

    Article  PubMed  PubMed Central  Google Scholar 

  12. Zoller B, Li X, Sunquist J, Sunquist K (2012) Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden. Lancet 379:244–249

    Article  PubMed  Google Scholar 

  13. Johannesdottir SA, Schmidt M, Horvath-Puho E et al (2012) Autoimmune skin and connective tissue diseases and risk of venous thromboembolism: a population-based case–control study. J Thromb Haemost 10:815–821

    Article  PubMed  CAS  Google Scholar 

  14. Biasillio G, Leo M, Della Bona R et al (2010) Inflammatory biomarker and coronary artery disease: from bench to bedside and back. Intern Emerg Med 5:225–233

    Article  Google Scholar 

  15. Jezovnik MK, Poredos P (2010) Idiopathic venous thrombosis is related to systemic inflammatory response and to increased levels of circulating markers of endothelial dysfunction. Int Angiol 29:226–231

    PubMed  CAS  Google Scholar 

  16. Fumery M, Xiaocang C, Dauchet L et al (2013) Thrombotic events and cardiovascular mortality in inflammatory bowel diseases: a meta-analysis of observational studies. J Crohns Colitis, 29 Oct 2013 [Epub ahead of print]

  17. Ungprasert P, Leeaphorn N, Hosiriluck N et al (2013) Clinical features of inflammatory myopathies and their association with malignancy: a systematic review in Asian population. ISRN Rheumatol 2013:509354

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Conflict of interest

The authors have no financial or nonfinancial conflict of interest to declare.

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand

    Patompong Ungprasert

  2. Department of Preventive and Social Medicine, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand

    Anawin Sanguankeo

Authors
  1. Patompong Ungprasert
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anawin Sanguankeo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Patompong Ungprasert.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ungprasert, P., Sanguankeo, A. Risk of venous thromboembolism in patients with idiopathic inflammatory myositis: a systematic review and meta-analysis. Rheumatol Int 34, 1455–1458 (2014). https://doi.org/10.1007/s00296-014-3023-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-014-3023-1

Keywords

Search

Navigation